Identification of Philadelphia-negative granulocyte-macrophage colony-forming units generated by stroma-adherent cells from chronic myelogenous leukemia patients.
Carlo-Stella C
Blood. 83(5):1373-80.
Acquired cyclic thrombocytopenia-thrombocytosis with periodic defect of platelet function.
Balduini CL
Br J Haematol. 85(4):718-22.
Use of recombinant human granulocyte-macrophage colony-stimulating factor in patients with lymphoid malignancies transplanted with unpurged or adjusted-dose mafosfamide-purged autologous marrow.
Carlo-Stella C
Blood. 80(9):2412-8.
Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
Carlo-Stella C
Exp Hematol. 20(3):328-33.
Tumor necrosis factor alpha modulates the messenger RNA expression of hematopoietic growth factor genes in fresh blast cells from patients with acute myeloblastic leukemia.
Bergamaschi G
Leukemia. 5(10):886-91.
In vitro marrow purging in chronic myelogenous leukemia: effect of mafosfamide and recombinant granulocyte–macrophage colony-stimulating factor.
Carlo-Stella C
Bone Marrow Transplant. 8(4):265-73.
Regulation of early hematopoiesis in serum-deprived cultures of mafosfamide-treated and untreated CD34-enriched bone marrow cells.
Ottmann OG
Exp Hematol. 19(8):773-8.
Human peripheral blood mononuclear cell subfractionation using counterflow centrifugation elutriation.
Almici C
Haematologica. 76(2):89-93.
Establishment and characterization of a B-cell line derived from a patient with a myelodysplastic syndrome which expresses myelomonocytic and lymphoid markers.
Bergamaschi G
Br J Haematol. 78(2):167-72.
Growth of CD34+ acute myeloblastic leukemia colony-forming cells in response to recombinant hematopoietic growth factors.
Carlo-Stella C
Leukemia. 4(8):561-6.